Position in VRTX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,365,510
+$150,475 QoQ
Shares Held
2,749
+1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#777
of 1,745 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $5,779,268 across 11 Biotechnology names. VRTX ranks #2 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
23,928 | $1,872,844 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,749 | $1,365,510 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
65,576 | $1,112,824 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
721 | $387,140 | |
| 5 | MRNA |
Moderna, Inc.
|
4,477 | $313,524 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,454 | $272,467 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,774 | $144,598 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
3,554 | $125,776 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,365,510 | 2,749 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,215,035 | 2,721 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,331,064 | 2,936 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,185,494 | 3,027 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $1,056,014 | 2,372 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $1,120,419 | 2,311 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $803,386 | 1,995 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $864,118 | 1,858 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $735,421 | 1,569 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $599,008 | 1,433 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $236,403 | 581 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $161,699 | 465 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $135,133 | 384 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $143,356 | 455 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $117,822 | 408 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $132,030 | 456 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $100,880 | 358 | Shares | Sole | 2022-08-02 | |
| 2021-03-31 | $806,697 | 3,754 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,065,893 | 4,510 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,189,980 | 4,373 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,284,912 | 4,426 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $297,199 | 1,249 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||